Veracyte, Inc. Income Statement
VCYT / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Veracyte, Inc. reported $517M in revenue and $66M in net income for FY2025. Revenue has grown at a 45.8% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $517.1M | $445.8M | $361.1M | $296.5M | $219.5M | $117.5M | $120.4M | $92.0M | $72.0M | $65.1M | $49.5M | $38.2M | $21.9M | $11.6M | $2.6M |
| Cost of Revenue | - | - | - | - | - | - | $36.1M | $33.1M | $28.2M | $25.5M | $21.5M | $16.6M | $12.6M | $7.6M | $2.9M |
| Gross Profit | $362.5M | $298.1M | $229.7M | $175.7M | - | - | - | - | - | - | - | - | - | - | - |
| SG&A Expense | $110.8M | $110.6M | $86.2M | $73.2M | $101.4M | $36.7M | $29.0M | $24.0M | $23.1M | $23.8M | $22.6M | $18.9M | $12.1M | $7.9M | $5.4M |
| R&D Expense | $70.8M | $69.3M | $57.3M | $40.6M | $29.8M | $17.2M | $14.9M | $14.8M | $13.9M | $15.3M | $12.8M | $9.8M | $7.8M | $6.6M | $6.7M |
| Operating Income | $57.8M | $16.1M | -$85.8M | -$41.1M | -$81.9M | -$35.4M | -$15.1M | -$22.2M | -$26.5M | -$28.8M | -$33.5M | -$29.0M | -$23.2M | -$18.9M | -$15.3M |
| Interest Expense | - | - | - | - | - | $229.0K | $677.0K | $2.0M | $4.9M | $2.8M | $378.0K | $439.0K | $233.0K | - | - |
| Income Tax | $1.8M | $1.6M | -$2.2M | $133.0K | -$6.1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - |
| Net Income | $66.4M | $24.1M | -$74.4M | -$36.6M | -$75.6M | -$34.9M | -$12.6M | -$23.0M | - | - | - | - | - | - | - |
| EPS (Basic) | -$1.02 | -$0.51 | -$1.11 | -$0.66 | -$0.27 | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$1.02 | -$0.51 | -$1.11 | -$0.66 | -$0.27 | -$0.62 | -$0.91 | -$1.09 | -$1.30 | -$1.36 | -$6.15 | -$28.68 | -$24.90 | - | - |
| Shares Outstanding | 77.8M | 73.3M | 72.0M | 71.1M | 58.2M | 49.6M | 40.9M | 33.8M | 33.8M | 27.7M | 22.5M | 21.1M | 667.7K | 650.3K | 580.1K |
| Gross Margin | 70.1% | 66.9% | 63.6% | 59.2% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin | 11.2% | 3.6% | -23.8% | -13.9% | -37.3% | -30.1% | -12.6% | -24.2% | -36.9% | -44.3% | -67.6% | -75.9% | -105.9% | - | - |
| Profit Margin | 12.8% | 5.4% | -20.6% | -12.3% | -34.4% | -29.7% | -10.5% | -25.0% | - | - | - | - | - | - | - |